[HTML][HTML] Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer
J Liu, X Jiao, Q Gao - Drug discovery today, 2020 - Elsevier
Highlights•Platinum-resistant diseases are related to worst prognosis in ovarian
cancers.•Neoadjuvant chemotherapy may be related to platinum resistance clinically.•Why …
cancers.•Neoadjuvant chemotherapy may be related to platinum resistance clinically.•Why …
Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer.
J Liu, X Jiao, Q Gao - Drug Discovery Today, 2020 - europepmc.org
Neoadjuvant chemotherapy (NACT) has been regarded a standard treatment for advanced
ovarian cancers for decades. Among patients who are poor candidates for primary …
ovarian cancers for decades. Among patients who are poor candidates for primary …
Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer
J Liu, X Jiao, Q Gao - Drug discovery today, 2020 - pubmed.ncbi.nlm.nih.gov
Neoadjuvant chemotherapy (NACT) has been regarded a standard treatment for advanced
ovarian cancers for decades. Among patients who are poor candidates for primary …
ovarian cancers for decades. Among patients who are poor candidates for primary …